The market in India for pharmaceutical fine chemicals is prospering, boosted by the successful recombination of the factors affordability and innovation. A strong record of cost-effective generic drugs production for a long time attracts world leaders who want to buy drugs at favourable prices that are a result of skilled labour and efficient manufacturing. Moreover, the Indian drug sector's increasing concentration on R&D has also created an opportunity for fine chemicals which are... >>More
Vijay Charlu, President, Corona Remedies
Sandip Dey, Chief Business Officer, Akumentis Healthcare & Nicholas Healthcare
Dr. TG Chandrashekar, Executive Director, Kusum Group of Companies
Tarun Kumar, CEO, Lord’s Mark Biotech
Sourabh Tiwari, CIO, Meril Group of Companies